Z-1272-2015Class II

BD Posiflush Saline Flush Syringe 10 ml inlcuded in the following device kits: PowerLoc Port Access Kit 19G x...

Name: Z-1272-2015 BD Posiflush Saline Flush Syringe 10 ml inlcuded in the following device kits: PowerLoc Port Access Kit 19G x...
Creator: Bard Access Systems
Published: 2014-08-08
License: https://open.fda.gov/license/

Bard Access Systems, Inc. / initiated 2014-08-08 / Terminated / root cause: manufacturing process

FDA source

Bard Access Systems began a recall of BD Posiflush Saline Flush Syringe 10 ml inlcuded in the following device kits: PowerLoc Port Access Kit 19G x 1 in, PowerLoc Port Access Kit 20G x 1 in... on 2014-08-08. FDA classified it as Class II and gives the reason as "Some unit packages of BD PosiFlush SF Saline Flush Syringe 10 mL may exhibit open seals, which could impact product sterility. Bard includes these pouched syringes, attached to some configurations of PICC kits, Port...". As of 2026-09-10, the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number: Z-1272-2015
Classification: Class II
Status: Terminated
Initiated: 2014-08-08
Posted: 2015-03-13
Terminated: 2015-08-05
Recalling firm: Bard Access Systems, Inc.
Product: BD Posiflush Saline Flush Syringe 10 ml inlcuded in the following device kits: PowerLoc Port Access Kit 19G x 1 in, PowerLoc Port Access Kit 20G x 1 in, , , PowerLoc Port Access Kit 20G x 1.5in, PowerLoc Port Access Kit 20G x 0.75in, , , PowerLoc Port Access Kit 22G x 1 in, PowerLoc Port Access Kit 22G x 0.75in, , PowerLoc Port Access Kit 19G x 1 in with Y-Site, , , PowerLoc Port Access Kit 19G x 0.75in with Y-Site, PowerLoc Port Access Kit 20G x 1 in with Y-Site, PowerLoc Port Access Kit 20G x 0.75in with Y-Site The syringe is used to pre-flush the catheter prior to placement and may also be used to verify patency post-placement.
Product code: LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Reason for recall: Some unit packages of BD PosiFlush SF Saline Flush Syringe 10 mL may exhibit open seals, which could impact product sterility. Bard includes these pouched syringes, attached to some configurations of PICC kits, Port Access kits (PAK), PowerGlide kits, Midline kits, and Convenience kits.
Root cause tag: manufacturing process
FDA root cause: Nonconforming Material/Component
Action: The firm, BD Medical, sent an "URGENT VOLUNTARY PRODUCT RECALL" letter dated July 22, 2014 and a follow-up "URGENT: Voluntary Product Recall-BD PosiFlush SF Saline Flush Syringe 10mL with rework instructions for applicable Bard Kits" letter dated August 8, 2014 to its customers and distributors. The letters described the product, problem and actions to be taken. The customers were instructed to immediately review your inventory and quarantine product subject to the recall; complete and return the Recall Response Card form via fax to BD at 1-201-847-6990 or email to [email protected] and return all affected products. Note: If you do not have any of the affected lots in your inventory, please complete the Recall Response Card form indicating you have (0) quantity and fax or email. The distributors were instructed to immediately examine your inventory and identify any product subject to this notification. In addition, if you have further distributed this product, please identify your customers and notify them at once of this notification. Complete the attached Recall Reply Form and FAX to Bard Access Systems, Inc. at 1-801-522-5674, or EMAIL to [email protected]. Even if you do not have any inventory of the affected syringe lots. Please direct any return requests and questions to our coordinator at 800-290-1689. If you have any questions or require assistance with the return of the recalled product and/or availability of replacement product, please contact BD Customer Service at 1-888-237-2762 option 3.
Quantity in commerce: 16,410 units
Distribution: US Nationwide Distribution.
Product codes and lots: Lot Numbers: REYE1714, REYE1713, REXD1617, REXE0089, REXE0077, REYE1233, REXE0085, REXE0971, REYE1709, REYE1579, REXD2157, REYE1269, REXD1932, REXE0826, REXE0086, REXD2155, REXD2156, REXE0697. Product codes: 2651910, 2652010, 2652015, 2652034, 2652210, 2652234, 2671910, 2671934, 2672010, 2672034.

Enforcement reports

One row per recalled product line

FDA enforcement reports joined to recall event Z-1272-2015
Recall number	Class	Status	Voluntary or mandated	Report date	Classified
Z-1271-2015	Class II	Terminated	Voluntary: Firm initiated	2015-03-25	2015-03-13
Z-1272-2015	Class II	Terminated	Voluntary: Firm initiated	2015-03-25	2015-03-13
Z-1273-2015	Class II	Terminated	Voluntary: Firm initiated	2015-03-25	2015-03-13
Z-1274-2015	Class II	Terminated	Voluntary: Firm initiated	2015-03-25	2015-03-13
Z-1275-2015	Class II	Terminated	Voluntary: Firm initiated	2015-03-25	2015-03-13

Product code LJT

K060812Class IIPowerport(tm)implanted Titanium Port W/8 Fr. Chronoflex Catheter-MultipleC.R. Bard, Inc. / cleared 2006-07-14

MDM coverage of this record lists here, newest first.

About this record

Sourced from the FDA device recall database and the FDA enforcement reports, both ingested from openFDA. The recall record supplies the product, the reason and the product code; the enforcement report supplies the classification. The two datasets are exported by FDA on different days, and the date above is the older of the two, so nothing on this page is newer than it says.

MDM adds the root cause tag, derived from FDA’s own root cause text, and the cross-links to the product code, the clearances named on the record and MDM coverage. Where a recall has not been joined to an enforcement report, no classification is shown.

Data as of 2026-10-14, the FDA export date for this dataset. Page last changed 2026-09-05. View this recall on fda.gov (opens on fda.gov)